Greater vascularity, lowered HIF-1/DNA binding, and elevated GSH as markers of adaptation to in vivo chronic hypoxia

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 287, Issue 3 31-3, 2004, Pages

  Tissot Van Patot, M C ^a   Bendrick Peart, J ^a   Beckey, V E ^a   Serkova, N ^a   Zwerdlinger, L ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b St Vincent's Hospital   (United States)

Author keywords

Glutathione SH; Placenta; Stereology; Succinate

Indexed keywords

ADENOSINE DIPHOSPHATE; BIOLOGICAL MARKER; ENOLASE; ESTER DERIVATIVE; FORMALDEHYDE; GLUTATHIONE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; LIQUID NITROGEN; PHOSPHOMONOESTER DERIVATIVE; SUCCINIC ACID; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VON HIPPEL LINDAU PROTEIN;

ADULT; ALTITUDE; ALTITUDE ACCLIMATIZATION; ANGIOGENESIS; ARTICLE; BLOOD FLOW; CAPILLARY DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PLACENTA CIRCULATION; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRESS; TISSUE LEVEL; VASCULARIZATION; WESTERN BLOTTING;

ADAPTATION, PHYSIOLOGICAL; ALTITUDE; ANOXIA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; GLUTATHIONE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 4143070143     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00203.2003     Document Type: Article

References (32)

1. Benirschke K and Kaufmann P. Pathology of the Human Placenta. New York: Springer-Verlag, 1995.
2. Brekken RA and Thorpe PE. Vascular endothelial growth factor and vascular targeting of solid tumors. Anticancer Res 21: 4221-4229, 2001.
3. Burton GJ, Reshetnikova OS, Milovanov AP, and Teleshova OV. Stereological evaluation of vascular adaptations in human placental villi to differing forms of hypoxic stress. Placenta 17: 49-55, 1996.
4. Caceda R, Gamboa JL, Boero JA, Monge CC, and Arregui A. Energetic metabolism in mouse cerebral cortex during chronic hypoxia. Neurosci Lett 301: 171-174, 2001.
5. Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M, and Post M. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGF-beta(3). J Clin Invest 105: 577-587, 2000.
6. 2 sensing. J Biol Chem 275: 25130-25138, 2000.
7. Ehleben W, Bolling B, Merten E, Porwol T, Strohmaier AR, and Acker H. Cytochromes and oxygen radicals as putative members of the oxygen sensing pathway. Respir Physiol 114: 25-36, 1998.
8. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, and Semenze GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613, 1996.
9. Genbacev O, Krtolica A, Kaelin W, and Fisher SJ. Human cytotrophoblast expression of the von Hippel-Lindau protein is downregulated during uterine invasion in situ and upregulated by hypoxia in vitro. Dev Biol 233: 526-536, 2001.
10. 2-evoked regulation of HIF-1α and NF-κB in perinatal lung epithelium requires glutathione biosynthesis. Am J Physiol Lung Cell Mol Physiol 278: L492-L503, 2000.
11. Haddad JJ, Olver RE, and Land SC. Antioxidant/pro-oxidant equilibrium regulates HIF-1alpha and NF-kappa B redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J Biol Chem 275: 21130-21139, 2000.
12. 2 sensor for hypobaric hypoxia in Andean high-altitude natives. Bioessays 25: 515-519, 2003.
13. Hultgren HN. High Altitude Medicine. Stanford, CA: Hultgren, 1997.
14. Kingdom JCP and Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta 18: 613-621, 1997.
15. Kumazaki K, Nakayama M, Suehara N, and Wada Y. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions. Hum Pathol 33: 1069-1077, 2002.
16. Lu S, Gu X, Hoestje S, and Epner DE. Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter. Biochim Biophys Acta 1574: 152-156, 2002.
17. Mayhew TM. Changes in fetal capillaries during preplacental hypoxia: growth, shape remodelling and villous capillarization in placentae from high-altitude pregnancies. Placenta 24: 191-198, 2003.
18. Paddenberg R, Goldenberg A, Faulhammer P, Braun-Dullaeus RC, and Kummer W. Mitochondrial complex II is essential for hypoxia-induced ROS generation and vasoconstriction in the pulmonary vasculature. Adv Exp Med Biol 536: 163-169, 2003.
19. Palmer SK, Moore LG, Young DZ, Cregger B, Berman JC, and Zamudio S. Increased preeclampsia and altered blood pressure course during normal pregnancy at high (3100 m) altitude in Colorado. Am J Obstet Gynecol 180: 1161-1168, 1999.
20. Pridjian G and Puschett JB. Preeclampsia. Part 1: clinical and pathophysiologic considerations. Obstet Gynecol Surv 57: 598-618, 2002.
21. Pufe T, Petersen W, Tillmann B, and Mentlein R. The angiogenic peptide vascular endothelial growth factor is expressed in foetal and ruptured tendons. Virchows Arch 439: 579-585, 2001.
22. Punkt K, Welt K, and Schaffranietz L. Changes of enzyme activities in the rat myocardium caused by experimental hypoxia with and without ginkgo biloba extract EGb 761 pretreatment. A cytophotometrical study. Acta Histochem 97: 67-79, 1995.
23. Rajakumar RA and Conrad KP. Expression, ontogeny and regulation of hypoxia inducible transcription factors in the human placenta (Abstract). J Soc Gynecol Investig 7: 184A, 2000.
24. Rajakumar RA, Whitelock KA, Weissfeld LA, Daftary AR, Markovic N, and Conrad KP. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2α, in placentas from women with preeclampsia. Biol Reprod 64: 499-506, 2001.
25. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88: 1474-1480, 2000.
26. Serkova N, Bendrick-Peart J, Alexander B, and Tissot van Patot MC. Metabolite concentrations in human placentae and their changes due to the collection time after delivery. Placenta 24: 227-235, 2003.
27. Serkova N, Jacobsen W, Niemann CU, Litt L, Benet LZ, Leibfritz D, and Christians U. Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain. Br J Pharmacol 133: 875-885, 2001.
28. Singh SN, Vats P, Kumria MM, Ranganathan S, Shyam R, Arora MP, Jain CL, and Sridharan K. Effect of high altitude (7,620 m) exposure on glutathione and related metabolism in rats. Eur J Appl Physiol 84: 233-237, 2001.
29. Sumbayev VV, Budde A, Zhou J, and Brune B. HIF-1 alpha protein as a target for S-nitrosation. FEBS Lett 535: 106-112, 2003.
30. Tissot van Patot MC, Grilli A, Chapman P, Broad E, Tyson W, Heller DS, Zwerdlinger L, and Zamudio S. Remodelling of uteroplacental arteries is decreased in high altitude placentae. Placenta 24: 326-335, 2003.
31. 2- regulated gene expression. FASEB J 16: 1151-1162, 2002.
32. Wiesener MS, Jurgensen JS, Rosenberger C, Scholze CK, Horstrup JH, Warnecke C, Mandriota S, Bechmann I, Frei UA, Pugh CW, Ratcliffe PJ, Bachmann S, Maxwell PH, and Eckardt KU. Widespread hypoxia-inducible expression of HIF-2α in distinct cell populations of different organs. FASEB J 17: 271-273, 2003.